Search

Your search keyword '"G. PFISTER"' showing total 39 results
Start Over Author "G. PFISTER" Journal journal of urology
39 results on '"G. PFISTER"'

1. MP40-02 THE COMBINATION OF MICRORNA-371A-3P AND 375-5P CAN DISTINGUISH VIABLE GERM CELL TUMOR AND TERATOMA FROM NECROSIS IN POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION SPECIMENS

Author

Lara Kremer, Martin Hellmich, Barbara Koeditz, Tim Nestler, David G. Pfister, Maike Wittersheim, Axel Heidenreich, Pia Paffenholz, and Melanie von Brandenstein

Subjects
Pathology, medicine.medical_specialty, Necrosis, business.industry, Urology, medicine.medical_treatment, medicine.disease, Retroperitoneal lymph node dissection, medicine.anatomical_structure, microRNA, medicine, Teratoma, medicine.symptom, business, Germ cell
Published
2021

2. PD57-12 WHICH PATIENTS WITH OLIGOMETASTATIC PROSTATE CANCER SHOULD BE CONSIDERED FOR CYTOREDUCTIVE RADICAL PROSTATECTOMY AS PART OF A MULTIMODAL TREATMENT? RESULTS FROM A LARGE, MULTI-INSTITUTIONAL COLLABORATION

Author

Antony Pellegrino, R. Jeffrey Karnes, Alberto Briganti, Carlo Andrea Bravi, Riccardo Leni, Armando Stabile, Nicola Fossati, Bernhard Grubmüller, Giorgio Gandaglia, Simone Scuderi, Marco Moschini, Daniele Robesti, Elio Mazzone, Andrea Gallina, Shahrok Shariat, Axel Heidenreich, David G. Pfister, Andrea Necchi, Francesco Montorsi, Nazareno Suardi, Donato Cannoletta, Vito Cucchiara, and Giuseppe Fallara

Subjects
Oncology, medicine.medical_specialty, Prostate cancer, Prostatectomy, business.industry, Urology, Internal medicine, medicine.medical_treatment, Preoperative risk, medicine, Multimodal treatment, business, medicine.disease
Abstract

INTRODUCTION AND OBJECTIVE:Cytoreductive radical prostatectomy (cRP) might be an option in oligometastatic prostate cancer (PCa). However, no preoperative risk tool is available to select candidate...

Published
2021

3. MP11-11 VALIDATION AND IMPLEMENTATION OF A MOBILE APP DECISION SUPPORT SYSTEM FOR QUALITY ASSURANCE OF MULTIDISCIPLINARY TUMOR BOARDS (MTD) TO OPTIMIZE MANAGEMENT OF ADVANCED TESTICULAR CANCER

Author

Thomas Elter, Axel Heidenreich, Michael Hallek, Yasemin Ural, and David G. Pfister

Subjects
Decision support system, medicine.medical_specialty, business.industry, Urology, Mobile apps, Guideline, medicine.disease, Multidisciplinary approach, medicine, Medical physics, Testis cancer, business, Quality assurance, Testicular cancer
Abstract

INTRODUCTION AND OBJECTIVE:As has been shown recently guideline-compliance is suboptimal concerning the management of testis cancer. Guideline incompliance results in significantly impaired long-te...

Published
2020

4. MP79-07 VALIDATION AND IMPLEMENTATION OF A MOBILE APP DECISION SUPPORT SYSTEM FOR QUALITY ASSURANCE OF TUMOR BOARDS. ANALYZING THE CONCORDANCE RATES FOR PROSTATE CANCER AT A MULTIDISCIPLINARY TUMOR BOARD OF A TERTIARY REFERRAL CENTRE

Author

Rabi R Datta, Yasemin Ural, Michael Hallek, David G. Pfister, Robert Kleinert, Thomas Elter, Yasemin Yilmaz, and Axel Heidenreich

Subjects
Decision support system, medicine.medical_specialty, business.industry, Urology, Concordance, Mobile apps, Cancer, Certification, medicine.disease, Prostate cancer, Multidisciplinary approach, Medicine, Medical physics, business, Quality assurance
Abstract

INTRODUCTION AND OBJECTIVE:Certified Cancer Centers are instructed to present 100% of all cases at multidisciplinary tumor boards (MTD). Discussion of standard cases limits the time of more demandi...

Published
2020

5. PD63-02 RELIABILITY OF MODERN IMAGING STUDIES FOR DETECTION AND FINAL PATHOHISTOLOGICAL STAGE IN MEN UNDERGOING RADICAL SALVAGE PROSTATECTOMY (RSP) FOR RADIORECURRENT PROSTATE CANCER (RPC)

Author

Jeff R. Karnes, Fahad Quhal, David G. Pfister, Shahrokh F. Shariat, Patricia John, and Axel Heidenreich

Subjects
medicine.medical_specialty, Prostate biopsy, medicine.diagnostic_test, business.industry, Urology, Biochemical diagnosis, medicine.disease, Prostate cancer, mental disorders, Biopsy, medicine, sense organs, Radiology, Stage (cooking), business, Salvage prostatectomy, psychological phenomena and processes, Reliability (statistics)
Abstract

INTRODUCTION AND OBJECTIVE:RPC is a biochemical diagnosis and it requires a positive prostate biopsy prior to RSP. A positive biopsy does not distinguish between locally recurrent or metastatic dis...

Published
2020

7. PD16-02 ONCOLOGICAL AND FUNCTIONAL OUTCOMES OF CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IN MEN WITH METASTATIC HORMONE-NAIVE PROSTATE CANCER (MHNPCA)

Author

Nicola Fossati, Shahrokh F. Shariat, Giorgio Gandaglia, David G. Pfister, Francesco Montorsi, Jeff R. Karnes, Alberto Briganti, Axel Heidenreich, Elio Mazzone, and Bernhard Grubmüller

Subjects
Oncology, medicine.medical_specialty, business.industry, Prostatectomy, Urology, medicine.medical_treatment, medicine.disease, Radiation therapy, Prostate cancer, Survival benefit, Internal medicine, medicine, Hormone naive, business
Abstract

INTRODUCTION AND OBJECTIVE:Whereas radiation therapy of the local primary exerts longterm survival benefit in nmhPCA with low metastatic burden, the role of cRP is still unclear. It was the purpose...

Published
2020

8. MP79-16 LONG-TERM RESULTS OF CYTOREDUCTIVE RADICAL PROSTATECTOMY IN MEN WITH HORMONE-NAIVE, LOW VOLUME METASTATIC PROSTATE CANCER(MHNPCA)

Author

David G. Pfister, Patricia John, Axel Heidenreich, and Florian Hartmann

Subjects
medicine.medical_specialty, business.industry, medicine.drug_class, Prostatectomy, Urology, medicine.medical_treatment, Apalutamide, Long term results, Androgen, medicine.disease, Low volume, Abiraterone, chemistry.chemical_compound, Prostate cancer, chemistry, medicine, Hormone naive, business
Abstract

INTRODUCTION AND OBJECTIVE:Androgen deprivation combined with apalutamide, abiraterone or docetexal represents the treatment of choice in mhnPCA. Cytoreductive radical prostatectomy (cRP) has been ...

Published
2020

9. PD16-04 RADICAL PROSTATECTOMY VERSUS RADIOTHERAPY IN M1A AND LOW VOLUME M1B PROSTATE CANCER PATIENTS: AN INDIRECT COMPARISON WITH THE STAMPEDE TRIAL ARM H

Author

Steve Joniau, David G. Pfister, Antony Pellegrino, Wouter Everaerts, Shahrokh F. Shariat, Daniele Robesti, Nicola Fossati, Charlien Berghen, Giorgio Gandaglia, Simone Scuderi, Alberto Martini, Pierre I. Karakiewicz, Giovanni Motterle, Gaëtan Devos, Giuseppe Fallara, Bernhard Grubmüller, F. Scalvi, Francesco Montorsi, Alberto Briganti, Axel Heidenreich, and Jeffrey Karnes

Subjects
Oncology, medicine.medical_specialty, Prostatectomy, business.industry, Urology, medicine.medical_treatment, urologic and male genital diseases, medicine.disease, Indirect comparison, Radiation therapy, Low volume, Androgen deprivation therapy, Prostate cancer, Survival benefit, Internal medicine, medicine, business
Abstract

INTRODUCTION AND OBJECTIVE:The STAMPEDE trial recently demonstrated a survival benefit for patients with oligometastatic prostate cancer (PCa) treated with androgen deprivation therapy (ADT) plus p...

Published
2020

10. MP76-05 VALIDATION OF THE BEST MODELS TO PREDICT PATHOHISTOLOGY IN GERM CELL TUMOR PATIENTS UNDERGOING POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION

Author

Alessandro Nini, Bettina Baeßler, David G. Pfister, Tim Nestler, Peter Albers, Pia Paffenholz, Andreas Hiester, Martin Hellmich, and Axel Heidenreich

Subjects
medicine.medical_specialty, Retroperitoneal lymph node dissection, medicine.anatomical_structure, business.industry, Urology, medicine.medical_treatment, medicine, Radiology, business, Germ cell
Published
2020

11. PD57-12 THE IMPACT OF PERSISTENTLY ELEVATED PSA LEVELS ON PROGRESSION AND SURVIVAL OF PATIENTS UNDERGOING CYTOREDUCTIVE RADICAL PROSTATECTOMY FOR OLIGOMETASTATIC PROSTATE CANCER

Author

David G. Pfister, Francesco Montorsi, Nicola Fossati, Daniele Robesti, Elio Mazzone, Axel Heidenreich, Aldo Rizzo, Giuseppe Fallara, Pierre I. Karakiewicz, Gabriele Sorce, Antony Pellegrino, Francesco Pellegrino, Bernhard Grubmüller, Vincenzo Mirone, Alberto Briganti, Shahrokh F. Shariat, Andrea Gallina, Vito Cucchiara, Donato Cannoletta, F. Scalvi, Jeffrey Karnes, and Giorgio Gandaglia

Subjects
medicine.medical_specialty, Prostate cancer, genetic structures, business.industry, Prostatectomy, Urology, medicine.medical_treatment, medicine, business, medicine.disease, Elevated PSA
Abstract

INTRODUCTION AND OBJECTIVE:Cytoreductive radical prostatectomy (cRP) represents an option in oligo-metastatic prostate cancer (mPCa). However, the optimal multi-modal strategy of these men is unkno...

Published
2020

13. MP22-17 BIOCHEMICHAL RECURRENCE IN PROSTATE CANCER AFTER SALVAGE SURGERY IN CORRELATION TO THE SITE OF RECCURRENT DISEASE

Author

Friederike Haidl, David G. Pfister, and Yasmin Pullankavumkal

Subjects
medicine.medical_specialty, Prostatectomy, business.industry, Urology, medicine.medical_treatment, Disease, Diagnostic tools, medicine.disease, Radiation therapy, Prostate cancer, medicine, Salvage surgery, Radiology, business
Abstract

INTRODUCTION AND OBJECTIVES:Due to improved diagnostic tools salvage surgery is getting more popular after failure of primary local treatment as radical prostatectomy or radiotherapy. We analyzed P...

Published
2019

14. MP49-01 PREDICTORS OF THROMBOSIS IN TESTICULAR CANCER DURING PLATINUM-BASED CHEMOTHERAPY

Author

David G. Pfister, Martin Hellmich, Katharina Grein, Salem Johannes, Pia Paffenholz, Axel Heidenreich, Isabel Heidegger, and Tim Nestler

Subjects
Oncology, Chemotherapy, medicine.medical_specialty, endocrine system diseases, business.industry, Urology, medicine.medical_treatment, Internal medicine, medicine, medicine.disease, business, Thrombosis, Testicular cancer
Abstract

INTRODUCTION AND OBJECTIVES:Testicular cancer patients receiving platinum-based chemotherapy are at risk for the development of venous thromboembolic events. In this study, we aim to identify poten...

Published
2019

16. MP28-13 IDENTIFICATION OF DIFFERENTIALLY EXPRESSED GENES TO PREDICT RADIORESISTANT PROSTATE CARCINOMAS

Author

Maike Wittersheim, Stephan C. Schaefer, Reinhard Büttner, Margarete Odenthal, Axel Heidenreich, Martin Hellmich, Tim Nestler, and David G. Pfister

Subjects
business.industry, Urology, medicine.medical_treatment, medicine.disease, Radiation therapy, Prostate cancer, medicine.anatomical_structure, Differentially expressed genes, Prostate, Radioresistance, Cancer research, Medicine, Identification (biology), business
Abstract

INTRODUCTION AND OBJECTIVES:Although relapses after radiotherapy are common in prostate cancer (PCa) patients, there are no clinical models or markers to identify patients at high risk for radiores...

Published
2019

18. PD42-06 SALVAGE RADICAL PROSTATECTOMY (SRP) FOR RADIORESISTANT PROSTATE CANCER (PCA): OUTCOME ANALYSIS OF 2 TERTIARY REFERAL CENTRES

Author

Tobias Kohl, David G. Pfister, Axel Heidenreich, Matteo Soligo, Jeffrey Karnes, Markus Grabbert, and Alessandro Morlaco

Subjects
Oncology, medicine.medical_specialty, Prostate cancer, business.industry, Prostatectomy, Urology, Internal medicine, Radioresistance, medicine.medical_treatment, medicine, Outcome analysis, medicine.disease, business
Published
2018

22. MP24-05 UPPER URINARY TRACT DECOMPRESSION USING ILEAL URETER REPLACEMENT IN COMPARISON TO ENDOURETERAL THERMOEXPANDABLE STENT [MEMOKATH 051]

Author

David G. Pfister, Axel Heidenreich, Mustafa Al-Mahmid, and Ilgar Akbarov

Subjects
medicine.medical_specialty, Decompression, business.industry, 030503 health policy & services, Urology, medicine.medical_treatment, Stent, Ileal ureter, 03 medical and health sciences, 0302 clinical medicine, medicine, 030212 general & internal medicine, 0305 other medical science, business, Upper urinary tract
Published
2017

23. PD53-01 NON-GUIDELINE CONCORDANT TREATMENT OF TESTICULAR CANCER

Author

Axel Heidenreich, David G. Pfister, and Pia Paffenholz

Subjects
Oncology, medicine.medical_specialty, business.industry, Guideline-concordant Treatment, Urology, Internal medicine, medicine, business, medicine.disease, Testicular cancer
Published
2017

24. MP80-03 DISTRESS SCREENING IN PATIENTS WITH UROGENITAL MALIGNANCIES

Author

David G. Pfister, Pia Paffenholz, Maria Angerer-Shpilenya, Axel Heidenreich, and Johannes Salem

Subjects
medicine.medical_specialty, Genitourinary system, business.industry, Urology, Internal medicine, Medicine, In patient, Distress screening, business
Published
2017

26. MP50-11 THE ROLE OF SALVAGE EXTENDED LYMPH NODE DISSECTION (LND) IN PATIENTS WITH RISING PSA AND PET/CT SCAN DETECTED NODAL RECURRENCE OF PROSTATE CANCER

Author

Daniar Osmonov, Klaus-Peter Jünemann, Axel Heidenreich, David G. Pfister, Andrea K. Thissen, Alexey V. Aksenov, Daniel Porres, and Timur H. Kuru

Subjects
medicine.medical_specialty, PET-CT, business.industry, Urology, medicine.disease, Prostate cancer, Dissection, medicine.anatomical_structure, medicine, In patient, Radiology, NODAL, business, Lymph node
Published
2016

29. 471 DISTINGUISHING FEATURES OF ERG ONCOPROTEIN EXPRESSION AMONG MATCHED COHORTS OF AFRICAN-AMERICAN AND CAUCASIAN-AMERICAN PROSTATE CANCER PATIENTS

Author

David G. McLeod, Albert Dobi, Denise Young, Isabell A. Sesterhenn, Shiv Srivastava, Philip Rosen, David G. Pfister, Gyorgy Petrovics, and Yongmei Chen

Subjects
African american, Oncology, medicine.medical_specialty, business.industry, Urology, common, medicine.disease, Caucasian American, Prostate cancer, Internal medicine, common.group, medicine, business, Erg
Published
2012

30. 832 PROGNOSTIC CLINICAL PARAMETERS TO PREDICT THE NECESSITY OF RECONSTRUCTIVE VASCULAR SURGERY FOR PATIENTS WHO UNDERGO POSTCHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND) FOR ADVANCED NONSEMINATOUS GERM CELL TUMORS (NSGCT). RESULTS OF THE GERMAN TESTICULAR CANCER STUDY GROUP (GTCSG) AND THE ASSOCIATION OF UROLOGIC ONCOLOGY (AUO)

Author

Hans U. Schmelz, Klaus Peter Diekmann, Axel Heidenreich, David G. Pfister, and Christoph Winter

Subjects
Oncology, medicine.medical_specialty, business.industry, Urology, medicine.medical_treatment, Urologic Oncology, Vascular surgery, medicine.disease, Retroperitoneal lymph node dissection, Internal medicine, medicine, Radiology, Germ cell tumors, business, Testicular cancer
Published
2011

31. 1478 THE ROLE OF PREVIOUS TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) ON THE ACCURACY OF NOMOGRAMS TO PREDICT FINAL PATHOLOGICAL STAGE IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER (PCA)

Author

Bernhard Brehmer, Robin Epplen, David G. Pfister, Thomas van Erps, David Thüer, and Axel Heidenreich

Subjects
medicine.medical_specialty, business.industry, Prostatectomy, Urology, medicine.medical_treatment, Nomogram, medicine.disease, Prostate cancer, medicine, Stage (cooking), business, Pathological, Transurethral resection of the prostate
Published
2011

34. 638 COMPLICATIONS OF POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PCRPLND) IN ADVANCED NONSEMINOMATOUS GERM CELL TUMORS – FIRST RESULTS OF THE GERMAN TESTICULAR CANCER STUDY GROUP

Author

Peter Albers, Christian Winter, Maria Angerer-Shpilenya, Bernhard Brehmer, David G. Pfister, and Axel Heidenreich

Subjects
Oncology, medicine.medical_specialty, business.industry, Urology, medicine.medical_treatment, medicine.disease, Retroperitoneal lymph node dissection, Internal medicine, medicine, Radiology, Germ cell tumors, business, Post-chemotherapy, Testicular cancer
Published
2010

36. 1871 THE ROLE OF PREVIOUS TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) ON THE ACCURACY OF NOMOGRAMS TO PREDICT FINAL PATHOLOGICAL STAGE IN MEN UNDERGOING RADICAL PROSTATECTOMY FOR PROSTATE CANCER (PCA)

Author

Robin Epplen, David G. Pfister, Ketevan Toronjadze, David Thüer, Bernhard Brehmer, Peter Firek, and Axel Heidenreich

Subjects
medicine.medical_specialty, business.industry, Prostatectomy, Urology, medicine.medical_treatment, Nomogram, medicine.disease, Prostate cancer, medicine, Stage (cooking), business, Pathological, Transurethral resection of the prostate
Published
2010

Catalog

Books, media, physical & digital resources
See catalog results